Founders Financial Securities’s Boston Scientific BSX Stock Holding History

Founders Financial Securities’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$429K	Buy	+10,043	New	+$545K	0.02%	410

Other funds holding BSX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Founders Financial Securities's BSX Position: Q2 2026 in Review

Founders Financial Securities opened a new position in Boston Scientific (BSX) in Q2 2026: 10,043 shares worth $429K. The stake represents 0.02% of the portfolio and ranks #410 among its holdings.

1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

Founders Financial Securities held 10,043 shares of Boston Scientific worth $429K as of Q2 2026.
Boston Scientific was a new Founders Financial Securities position in Q2 2026.
Boston Scientific made up 0.02% of Founders Financial Securities's portfolio in Q2 2026, its #410 holding.
1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Founders Financial Securities's 13F filing for Q2 2026, filed 31 Jul 2026.